Page 6 of 8 – SEC Filing Item 5. Interest in Securities of the Issuer.
(a)-(c) As of the date hereof, Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler may be deemed to be the beneficial owner of 2,450,086 shares of Common Stock or 20.66% of the shares of the Common Stock of the Issuer, based upon the 11,856,481 shares of Common Stock outstanding as of August 16, 2016, according to the 9,869,815 shares of Common Stock outstanding on the Issuer’s 10-Q filed on August 11, 2016 and the 1,986,666 shares of Common Stock on Form 424(B)(5) filed on August 17, 2016. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler has the sole power to vote or direct the vote of 0 shares of Common Stock and the shared power to vote or direct the vote of 2,450,086 shares of Common Stock. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund and Kevin Kotler has the sole power to dispose or direct the disposition of 0 shares of Common Stock and the shared power to dispose or direct the disposition of 2,450,086 shares of Common Stock. On August 16, 2016, pursuant to the terms of a secondary offering, the Reporting Persons purchased 390,000 shares of Common Stock of the Issuer. There have been no other transactions in the securities of the Issuer during the last sixty days. The aforementioned shares of Common Stock were acquired for investment purposes. Broadfin Capital, LLC and Broadfin Healthcare Master Fund, Ltd. may acquire additional securities of the Issuer, dispose of all or some of these securities from time to time, in each case in open market or private transactions, block sales or purchases or otherwise, or may continue to hold the shares of Common Stock. The Reporting Persons specifically disclaim beneficial ownership in the shares of Common Stock reported herein except to the extent of their pecuniary interest therein.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
This Item is not applicable.
Item 7. Material to be Filed as Exhibits.
An agreement relating to the filing of a joint statement as required by Rule 13d-1(f) under the Securities Exchange Act of 1934 is filed herewith as Exhibit A.
| Item 5. | Interest in Securities of the Issuer. |
| (a)-(c) | As of the date hereof, Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler may be deemed to be the beneficial owner of 2,450,086 shares of Common Stock or 20.66% of the shares of the Common Stock of the Issuer, based upon the 11,856,481 shares of Common Stock outstanding as of August 16, 2016, according to the 9,869,815 shares of Common Stock outstanding on the Issuer’s 10-Q filed on August 11, 2016 and the 1,986,666 shares of Common Stock on Form 424(B)(5) filed on August 17, 2016. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler has the sole power to vote or direct the vote of 0 shares of Common Stock and the shared power to vote or direct the vote of 2,450,086 shares of Common Stock. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund and Kevin Kotler has the sole power to dispose or direct the disposition of 0 shares of Common Stock and the shared power to dispose or direct the disposition of 2,450,086 shares of Common Stock. On August 16, 2016, pursuant to the terms of a secondary offering, the Reporting Persons purchased 390,000 shares of Common Stock of the Issuer. There have been no other transactions in the securities of the Issuer during the last sixty days. The aforementioned shares of Common Stock were acquired for investment purposes. Broadfin Capital, LLC and Broadfin Healthcare Master Fund, Ltd. may acquire additional securities of the Issuer, dispose of all or some of these securities from time to time, in each case in open market or private transactions, block sales or purchases or otherwise, or may continue to hold the shares of Common Stock. The Reporting Persons specifically disclaim beneficial ownership in the shares of Common Stock reported herein except to the extent of their pecuniary interest therein. |
| Item 6. | Contracts, Arrangements, Understandings or Relationships with Respect | |
| to Securities of the Issuer. |
| This Item is not applicable. | ||
| Item 7. | Material to be Filed as Exhibits. |
| An agreement relating to the filing of a joint statement as required by Rule 13d-1(f) under the Securities Exchange Act of 1934 is filed herewith as Exhibit A. | ||
Follow Societal Cdmo Inc. (NASDAQ:SCTL)
Follow Societal Cdmo Inc. (NASDAQ:SCTL)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
